Interim results (3-year) of a French non-interventional study to assess the long-term safety and efficacy of BeneFIX

被引：0
|
作者：
Rothschild, C. [1 ]
Trossaert, M. [2 ]
Claeyssens-Donadel, S. [3 ]
Lambert, T. [4 ]
Hassoun, A. [5 ]
Volot, F. [6 ]
Attal, S. [7 ]
机构：
[1] Hop Necker Enfants Malad, Paris, France
[2] Hop Hotel Dieu, Nantes, France
[3] Purpan Hosp, Toulouse, France
[4] Kremlin Bicetre Hosp, Paris, France
[5] Simone Veil Hosp, Montmorency Foret, France
[6] Bocage Hosp, Dijon, France
[7] Pfizer, Paris, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：428 / 428
页数：1
相关论文
共 50 条
  • [1] Interim results (2-year) of a French non-interventional study to assess the long-term safety and efficacy of BeneFIX
    Rothschild, C.
    Trossaert, M.
    Claeyssens, S.
    Lambert, T.
    Hassoun, A.
    Volot, F.
    Dubanchet, A.
    HAEMOPHILIA, 2012, 18 : 23 - 24
  • [2] Four-year interim results of a non-interventional trial to assess the safety and efficacy of treatment with recombinant factor IX, BeneFIX®
    Hardewig, J.
    Oldenburg, J.
    Pollmann, H.
    HAEMOPHILIA, 2012, 18 : 24 - 24
  • [3] Two-year interim results of a non-interventional trial to assess the safety and efficacy of treatment with recombinant factor IX
    Westfeld, M.
    Pollmann, H.
    Oldenburg, J.
    HAEMOPHILIA, 2010, 16 : 32 - 32
  • [4] Impact of Age and Type of Underlying Disease on Long-Term Safety and Efficacy in Patients with Transfusional Hemosiderosis Treated with Deferasirox: Results from a 3-Year Non-Interventional Study (SENTINEL)
    Elalfy, Mohsen
    Inusa, Baba
    Beneitez, David
    Xicoy, Blanca
    Nieto, Maria Soledad Duran
    Bruederle, Andreas
    Azmon, Amin
    El-Beshlawy, Amal
    BLOOD, 2016, 128 (22)
  • [5] Efficacy and safety of tirbanibulin in actinic keratoses. Interim results of a non-interventional study
    Heppt, M.
    Hadshiew, I.
    Kempf, A.
    Melzer, A.
    Berking, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 69 - 70
  • [6] Fremanezumab Long-Term Efficacy and Safety: Interim Results of a One-Year Study
    Goadsby, P.
    Yeung, P. P.
    Blankenbiller, T.
    Grozinski-Wolff, M.
    Yang, R.
    Ma, Y.
    Ning, X.
    Aycardi, E.
    HEADACHE, 2018, 58 : 166 - 166
  • [7] LONG-TERM SAFETY OF ADALIMUMAB IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: INTERIM RESULTS OF A NON-INTERVENTIONAL REGISTRY, LEGACY
    Bossuyt, Peter
    Atreya, Raja
    Samso, Carlos Taxonera
    Hebuterne, Xavier
    Isaacs, Kim
    Higgins, Peter D.
    Lindsay, James O.
    Heap, Graham
    Arikan, Dilek
    Kuehnl, Vera
    Petersson, Joel H.
    Robinson, Anne M.
    Loftus, Edward V.
    GASTROENTEROLOGY, 2018, 154 (06) : S829 - S829
  • [8] Long-term safety of adalimumab in patients with moderate-to-severe ulcerative colitis: Interim results of a non-interventional registry, LEGACY
    Bossuyt, P.
    Atreya, R.
    Taxonera, C.
    Hebuterne, X.
    Isaacs, K.
    Higgins, P. D.
    Lindsay, J.
    Heap, G.
    Arikan, D.
    Kuehnl, V.
    Petersson, J.
    Robinson, A. M.
    Loftus, E. V., Jr.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S32 - S32
  • [9] Long-term safety and efficacy of renal sympathetic denervation in atrial fibrillation: 3-year results of the AFFORD study
    Zeijen, Victor J. M.
    Theuns, Dominic A.
    Feyz, Lida
    Saville, Kari A.
    Bhagwandien, Rohit
    Kardys, Isabella
    Van Mieghem, Nicolas M.
    Daemen, Joost
    CLINICAL RESEARCH IN CARDIOLOGY, 2023, 112 (12) : 1766 - 1777
  • [10] Long-term safety and efficacy of renal sympathetic denervation in atrial fibrillation: 3-year results of the AFFORD study
    Victor J. M. Zeijen
    Dominic A. Theuns
    Lida Feyz
    Kari A. Saville
    Rohit Bhagwandien
    Isabella Kardys
    Nicolas M. Van Mieghem
    Joost Daemen
    Clinical Research in Cardiology, 2023, 112 : 1766 - 1777
12345